|1.||Li, Hong: 4 articles (03/2007 - 01/2007)|
|2.||Lee, Minyoung: 3 articles (01/2012 - 08/2008)|
|3.||Lee, Yun-Sil: 3 articles (01/2012 - 08/2008)|
|4.||Taniguchi, Naoyuki: 3 articles (09/2010 - 03/2005)|
|5.||Wang, Peng-Hui: 3 articles (04/2007 - 07/2002)|
|6.||Yuan, Chiou-Chung: 3 articles (04/2007 - 07/2002)|
|7.||Chiricolo, Mariella: 3 articles (02/2006 - 01/2004)|
|8.||Dall'Olio, Fabio: 3 articles (02/2006 - 01/2004)|
|9.||Vallejo-Ruiz, Verónica: 2 articles (06/2012 - 03/2009)|
|10.||Reyes-Leyva, Julio: 2 articles (06/2012 - 03/2009)|
01/01/2007 - "To study the effects of antisense oligonucleotide (ASODN) targeting ST6Gal I on cell adhesion and invasiveness of human cervical carcinoma cell line HeLa which over-expressed ST6Gal I . "
10/01/2000 - "RT-PCR analysis of 14 carcinoma samples, all expressing an increased ST6Gal.I enzyme activity, and of the corresponding normal mucosa revealed the presence of at least 2 transcripts. "
01/01/2007 - "To study the effect of synthesized ST6Gal I specific siRNA on the adhesion and invasiveness of human colon carcinoma cell line SW480 with over expression of ST6Gal I. A double strand small interference RNA (siRNA) targeting ST6Gal I was designed and synthesized, and then transfected into SW480 cells by lipofectmine 2000. "
02/01/2007 - "[ST6Gal I siRNA and antisense oligonucleotide-mediated gene silencing lowers the invasiveness potential of colonic carcinoma cells]."
03/01/2007 - "[Combinatorial effects of ST6Gal I siRNA and antisense oligonucleotide-mediated gene silence on metastasis ability of cervical carcinoma cells]."
|2.||Colonic Neoplasms (Colon Cancer)
11/01/2001 - "In our previous studies, we have frequently observed a discrepancy between the ST6Gal.I level within a colon cancer sample or cell line and the respective level of reactivity with the alpha 2,6-sialyl-specific lectin from Sambucus nigra (SNA). "
01/01/2012 - "Both non-cleaved and cleaved forms of ST6Gal I significantly increased colon cancer cell migration in a sialylation-dependent manner. "
01/01/2012 - "Induction of ST6Gal I significantly increased the migration of colon cancer cells via sialylation of integrin β1. "
01/01/2012 - "Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells."
05/31/2001 - "Expression of ST6Gal I and its products is reportedly increased in colon cancers. "
|3.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/01/2003 - "Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma."
03/01/2009 - "Increased mRNA expression of STs (ST6Gal I, ST3Gal III) has been detected in invasive cervical squamous cell carcinoma. "
10/01/2001 - "ST6Gal I expression was enhanced in squamous cell carcinoma of the cervix (P = 0.026, Mann-Whitney U test), but mRNA expression from the other three STs (ST3Gal I, ST3Gal III, and ST3Gal IV) was significantly down-expressed in squamous cell carcinoma of the cervix compared to the normal cervix (P = 0.003, P < 0.001, and P = 0.001, respectively). "
01/01/2013 - "In summary, our results showed that the high expression of ST3Gal I and ST6Gal I, in skin tumors, is associated with tumors with greater potential for invasion and metastasis, as in the case of squamous cell carcinoma, and this may be related to their behavior."
01/01/2013 - "The expression of ST3Gal I was observed in actinic keratosis (53%), keratoacanthoma (78%), squamous cell carcinoma (73%) and basal cell carcinoma (32%) with statistic differences between basal cell carcinoma and keratoacanthoma (P=0.0239) and basal cell carcinoma and squamous cell carcinoma (P=0.0096); for ST6Gal I, cytoplasmic expression was noted in actinic keratosis (40%), heterogeneous and cytoplasmic expression was noted in keratoacanthoma (67%), squamous cell carcinoma (41%) and basal cell carcinoma (7%) with statistic differences between basal cell carcinoma and squamous cell carcinoma (P=0.0061) and basal cell carcinoma and keratoacanthoma (P=0.0008). "
|4.||Colorectal Neoplasms (Colorectal Cancer)
01/01/2005 - "Elevation of ST6Gal I activity in malignant and transitional tissue in human colorectal cancer."
01/01/2005 - "The aim of the present study was to investigate the activity of CMP-NeuAc:Galbeta(1,4)GlcNAc sialyltransferase (ST6Gal I) in colorectal cancer (CRC). "
08/08/2003 - "Previous studies have shown that hST6Gal I mRNA is overexpressed in colorectal cancer tissues compared with non-malignant or benign tissue. "
01/01/2009 - "Increased ST6Gal I activity has been associated with the alpha(2,6)sialylation enhancement of membrane glycoconjugates observed in metastatic colorectal carcinomas (CRC). "
06/01/2001 - "Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas."
01/01/2015 - "However, the increased α2,6 sialylation catalyzed by β-galactoside α2,6 sialyltranferase 1 (ST6Gal I) is frequently observed in many types of the cancers. "
01/01/2012 - "Here, we further investigated the mechanisms underlying ST6Gal I cleavage, solubilization and release from cells, and addressed its functions, focusing primarily on cancer cell migration. "
01/01/2007 - "ASODN and sense oligonucleotide (SODN) targeting ST6Gal I were designed and constructed, and transfected into a cervical cancer cell line, HeLa, by lipofectmine 2000. "
11/14/2005 - "Univariate analyses showed that both decreased tumor ST6Gal I activity (P = 0.028), increased serum msAFP percentage (P = 0.034) and poor tumor cell differentiation (P = 0.031) were associated with shorter overall survival. "
11/14/2005 - "Both decreased tumor ST6Gal I activity and increased serum msAFP percentage were associated with poor tumor cell differentiation. "
|2.||Small Interfering RNA (siRNA)
|3.||Messenger RNA (mRNA)
|5.||beta-D-galactoside alpha 2-6-sialyltransferase
|6.||N-Acetylneuraminic Acid (Sialic Acid)
|7.||Complementary DNA (cDNA)
|9.||RNA (Ribonucleic Acid)
|10.||Cytidine Monophosphate (CMP)